Scalp metastasis from esophageal adenocarcinoma

Cutis

Volumn 77, Issue 2, 2006, Pages 106-108

  Roh, Ellen K ^a   Nord, Roland ^b   Jukic, Drazen M ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; AGED; ARTICLE; CASE REPORT; ESOPHAGUS TUMOR; HUMAN; MALE; METASTASIS; PATHOLOGY; SCALP; SKIN TUMOR;

ADENOCARCINOMA; AGED; ESOPHAGEAL NEOPLASMS; HUMANS; MALE; SCALP; SKIN NEOPLASMS;

EID: 33645104233     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Daly JM, Karnell LH, Menck HR. National Cancer Data Base report on esophageal carcinoma. Cancer. 1996;78:1820-1828.
2. Goldschmid S, Nord HJ. Endoscopic diagnosis and treatment of esophageal cancer. Gastrointest Endosc Clin N Am. 1994;4:827-850.
3. Endo T, Tamaki K, Arimura Y, et al. Expression of sulfated carbohydrate chain and core peptides of mucin detected by monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma. J Gastroenterol. 1998;33:811-815.
4. Labouvie C, Machado JC, Carneiro F, et al. Differential expression of mucins and trefoil peptides in native epithelium, Barrett's metaplasia and squamous cell carcinoma of the esophagus. J Cancer Res Clin Oncol. 1999;125:71-76.
5. Rice TW, Adelstein DJ, Zuccaro G, et al. Advances in the treatment of esophageal carcinoma. Gastroenterologist. 1997;5:278-294.
6. Smith KJ, Williams J, Skelton H. Metastatic adenocarcinoma of the esophagus to the skin: new patterns of tumor recurrence and alternate treatments for palliation. J Cutan Pathol. 2001;28:425-431.
7. Guillem P, Billeret V, Buisine MP, et al. Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus. Int J Cancer. 2000;88:856-861.
8. Jankowski JA, Wright NA, Meltzer S, et al. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol. 1999;154:965-973.
9. Kahrilas P. It's not the American way-yet. Am J Gastroenterol. 1994;89:657-658.
10. Lagergren J, Bergstrom R, Adami HO, et al. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med. 2000;133:165-175.
11. Gray MR, Donnelly RJ, Kingsnorth AN. The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar linked oesophagus. Gut. 1993;34:727-731.
12. Freedman J, Ye W, Naslund E, et al. Association between cholecystectomy and adenocarcinoma of the esophagus. Gastroenterology. 2001;121:548-553.
13. Lieberman MD, Shriver CD, Bleckner S, et al. Carcinoma of the esophagus: prognostic significance of histologic type. J Thorac Cardiovasc Surg. 1995;109:130-139.
14. Moll R. Cytokeratins in the histological diagnosis of malignant tumors. Int J Biol Markers. 1994;9:63-67.
15. Al-Kasspooles M, Moore JH, Orringer MB, et al. Amplification and over-expression of the EGFR and erbB-2 genes in human esophageal adenocarcinomas. Int J Cancer. 1993;54:213-219.